Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
The company received $441,437 from the foundation to miniaturize its molecular point-of-care test for HIV viral load.
Acquired immunodeficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV) that attacks the body’s immune system, making it vulnerable to all infections. One of the major concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results